Stifel analyst Alex Thompson raised the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $4.00 (from $3.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE